125 related articles for article (PubMed ID: 24793964)
1. A strong interferon response correlates with a milder dengue clinical condition.
De La Cruz Hernández SI; Puerta-Guardo H; Flores-Aguilar H; González-Mateos S; López-Martinez I; Ortiz-Navarrete V; Ludert JE; Del Angel RM
J Clin Virol; 2014 Jul; 60(3):196-9. PubMed ID: 24793964
[TBL] [Abstract][Full Text] [Related]
2. Primary dengue virus infections induce differential cytokine production in Mexican patients.
Cruz Hernández SI; Puerta-Guardo HN; Flores Aguilar H; González Mateos S; López Martinez I; Ortiz-Navarrete V; Ludert JE; Angel RM
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):161-7. PubMed ID: 27008374
[TBL] [Abstract][Full Text] [Related]
3. Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever.
Bachal R; Alagarasu K; Singh A; Salunke A; Shah P; Cecilia D
Arch Virol; 2015 Oct; 160(10):2435-43. PubMed ID: 26175069
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dengue virus infections in a sample of patients suggests unique clinical, immunological, and virological profiles that impact on the diagnosis of dengue and dengue hemorrhagic fever.
Senaratne T; Wimalaratne H; Alahakoon DG; Gunawardane N; Carr J; Noordeen F
J Med Virol; 2016 Oct; 88(10):1703-10. PubMed ID: 26990973
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of interleukin-21 production during the clinical course of primary and secondary dengue virus infections.
Vivanco-Cid H; Maldonado-Rentería MJ; Sánchez-Vargas LA; Izaguirre-Hernández IY; Hernández-Flores KG; Remes-Ruiz R
Immunol Lett; 2014 Sep; 161(1):89-95. PubMed ID: 24858204
[TBL] [Abstract][Full Text] [Related]
6. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
Lau L; Green AM; Balmaseda A; Harris E
J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
[TBL] [Abstract][Full Text] [Related]
7. Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar.
Ngwe Tun MM; Thant KZ; Inoue S; Kurosawa Y; Lwin YY; Lin S; Aye KT; Thet Khin P; Myint T; Htwe K; Mapua CA; Natividad FF; Hirayama K; Morita K
J Med Virol; 2013 Jul; 85(7):1258-66. PubMed ID: 23595687
[TBL] [Abstract][Full Text] [Related]
8. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
[TBL] [Abstract][Full Text] [Related]
9. Dengue specific immunoglobulins M, A, and E in primary and secondary dengue 4 infected Salvadorian children.
Vazquez S; Lozano C; Perez AB; Castellanos Y; Ruiz D; Calzada N; Guzmán MG
J Med Virol; 2014 Sep; 86(9):1576-83. PubMed ID: 24615872
[TBL] [Abstract][Full Text] [Related]
10. Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue.
Upasani V; Scagnolari C; Frasca F; Smith N; Bondet V; Vanderlinden A; Lay S; Auerswald H; Heng S; Laurent D; Ly S; Duong V; Antonelli G; Dussart P; Duffy D; Cantaert T
Front Immunol; 2020; 11():605087. PubMed ID: 33391269
[TBL] [Abstract][Full Text] [Related]
11. Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.
Kyle JL; Balsitis SJ; Zhang L; Beatty PR; Harris E
Virology; 2008 Oct; 380(2):296-303. PubMed ID: 18774583
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak.
Chakravarti A; Kumaria R
Indian J Med Res; 2006 Jan; 123(1):25-30. PubMed ID: 16567864
[TBL] [Abstract][Full Text] [Related]
13. High levels of interferon alpha in the sera of children with dengue virus infection.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Ennis FA
Am J Trop Med Hyg; 1993 Feb; 48(2):222-9. PubMed ID: 8447527
[TBL] [Abstract][Full Text] [Related]
14. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
15. Primary dengue haemorrhagic fever in patients from northeast of Brazil is associated with high levels of interferon-β during acute phase.
Oliveira RA; Silva MM; Calzavara-Silva CE; Silva AM; Cordeiro MT; Moura PM; Baptista PN; Marques ET; Gil LH
Mem Inst Oswaldo Cruz; 2016 May; 111(6):378-84. PubMed ID: 27223651
[TBL] [Abstract][Full Text] [Related]
16. Serological markers during dengue 3 primary and secondary infections.
Vázquez S; Pérez AB; Ruiz D; Rodríguez R; Pupo M; Calzada N; González L; González D; Castro O; Serrano T; Guzmán MG
J Clin Virol; 2005 Jun; 33(2):132-7. PubMed ID: 15911428
[TBL] [Abstract][Full Text] [Related]
17. Indices of anti-dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase.
Posadas-Mondragón A; Aguilar-Faisal JL; Chávez-Negrete A; Guillén-Salomón E; Alcántara-Farfán V; Luna-Rojas L; Ávila-Trejo AM; Del Carmen Pacheco-Yépez J
Microbiol Immunol; 2017 Oct; 61(10):433-441. PubMed ID: 28881485
[TBL] [Abstract][Full Text] [Related]
18. Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence.
Soundravally R; Hoti SL; Patil SA; Cleetus CC; Zachariah B; Kadhiravan T; Narayanan P; Kumar BA
Int J Infect Dis; 2014 Jan; 18():68-72. PubMed ID: 24216294
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a dengue patient cohort in Recife, Brazil.
Cordeiro MT; Silva AM; Brito CA; Nascimento EJ; Magalhães MC; Guimarães GF; Lucena-Silva N; de Carvalho EM; Marques ET
Am J Trop Med Hyg; 2007 Dec; 77(6):1128-34. PubMed ID: 18165535
[TBL] [Abstract][Full Text] [Related]
20. Characterization of type I interferon responses in dengue and severe dengue in children in Paraguay.
Talarico LB; Byrne AB; Amarilla S; Lovera D; Vázquez C; Chamorro G; Acosta PL; Ferretti A; Caballero MT; Arbo A; Polack FP
J Clin Virol; 2017 Dec; 97():10-17. PubMed ID: 29078078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
